Mannitol


Article Author:
Steven Tenny
Roshan Patel


Article Editor:
William Thorell


Editors In Chief:
Shane Havens
Jim Wang
Koushik Tripathy


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Kyle Blair
Trevor Nezwek
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Daniyal Ameen
Altif Muneeb
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes
Komal Shaheen
Sandeep Sekhon


Updated:
9/15/2019 7:23:24 PM

Indications

Mannitol has four Food and Drug Administration (FDA)-approved uses.[1][2][3][4]

  1. Mannitol has approval for the reduction of intracranial pressure and brain mass. 
  2. Mannitol is approved to reduce intraocular pressure if this is not achievable by other means. 
  3. Mannitol can promote diuresis for acute renal failure to prevent or treat the oliguric phase before irreversible damage. 
  4. Mannitol can also promote diuresis to promote excretion of toxic substances, materials, and metabolites.

 There are multiple uses of mannitol which are not FDA-approved. 

  • Mannitol may be used to prime a heart and lung machine before putting the patient on heart-lung bypass. The mannitol may help to preserve renal function as the kidneys have decreased blood flow.  The mannitol is suspected to decrease renal cell swelling. 
  • Mannitol works to protect sharp objects as they get introduced into a vascular space. A mannitol cap on a pacemaker wire will protect the tip from becoming dulled while a clinician introduces it into the vascular system then the mannitol will readily dissolve away with minimal effect.
  • Mannitol may have utility as a challenge test for diagnosing asthma. 
  • Mannitol is a sweetener for diabetic food products. Mannitol is sugar but increases blood glucose to a lesser extent than some other sugars such as sucrose.

Mechanism of Action

Mannitol is a six-carbon, linear, simple sugar which is only mildly metabolized by the body and primarily excreted rapidly by the kidneys when given intravenously and poorly absorbed when taken orally. 

The FDA-approved indications for mannitol are all for intravenous mannitol and detailed below.

Mannitol for Increased Intracranial Pressure[4]

Mannitol may be used for the reduction of intracranial pressure. In this indication, mannitol administration is intravenous. Mannitol then constitutes a new solute in the plasma, which increases the tonicity of the plasma.  Since mannitol cannot cross the intact blood-brain barrier, the increased tonicity from the mannitol draws water out of the brain parenchyma and into the intravascular space. The water then travels with the mannitol to the kidneys where it gets excreted in the urine.

The mannitol causes the cells in the brain to dehydrate mildly. The water inside the brain cells (intracellular water) leaves the cells and enters the bloodstream as the mannitol draws it out of the cells and into the bloodstream. Once in the bloodstream, the extra water is whisked out of the skull.  When the mannitol gets to the kidneys, the kidneys filter the mannitol into the urine. The mannitol again draws the water with it, and diuresis (increased urination) ensues.

Mannitol to Reduce Intraocular Pressure[5]

Mannitol may be used to reduce intraocular pressure when given intravenously. The mannitol is a new solute in the intravascular space, which increases the tonicity of the blood plasma. The increased tonicity of the blood plasma draws water out of the vitreous humor of the eye and into the intravascular space. Once in the intravascular space, the mannitol and associate water are excreted by the kidney. The decreased water of the vitreous humor lowers the intraocular pressure.

The mannitol dehydrates the vitreous humor. The mannitol draws water out of the vitreous humor and into the blood vessels as it passes by. When the vitreous humor has less water, after being dehydrated by the mannitol, it has less mass and thus creates less pressure. The lower pressure is less likely to damage the retina. The mannitol remains in the blood vessels and is excreted, with its associated water, into the urine.

Mannitol to Promote Diuresis in Acute Renal Failure

Mannitol can be used in acute renal failure to help prevent or treat the oliguric phase. During the oliguric phase urine output decreases to less than 0.5 mg/kg/hour for children and less than 400 mL/day in adults. The fluid which does not get excreted remains in the body and cause fluid overload. Fluid overload causes issues such as decreased oxygenation and ventilation, electrolyte abnormalities, swelling, encephalopathy, and cardiac arrest. An individual with acute renal failure can sometimes be giving intravenous mannitol. Even during acute renal failure, much of mannitol excretion is by the kidneys. As the mannitol gets excreted, it draws water with it, which can increase the water excretion of the patient and help avoid or treat the fluid overload caused by oliguria in acute renal failure. However, Mannitol causes significant osmotic injury to tubules leading to ATN(acute tubular necrosis) so its use for this indication is almost obsolete.

Mannitol to Excrete Toxic Materials

Much like mannitol given for oliguria of acute renal failure, mannitol can be given to increase the excretion of toxic materials, substances, and drugs. The kidneys excrete mannitol. The mannitol is poorly reabsorbed once excreted and thus draws extra water with it into the renal collecting ducts. The extra water in the renal collecting ducts can help increase the excretion of water-soluble toxic materials, substances, and drugs.

Mannitol to Prevent Intradialytic Hypotension[6]

Intradialytic hypotension and dialysis disequilibrium symptoms are common in hemodialysis patients.  This is due to a drop in intradialytic osmolality. Mannitol can be used to prevent intradialytic hypotension by raising serum osmolality.

Additional Mechanisms of Action

Since mannitol is a sugar and it provides a sweet taste when ingested orally. Mannitol also mostly passes through the intestine and is excreted in the feces as the small intestine absorbs it poorly. Thus, mannitol is used as a sweetener in food for diabetic patients as mannitol can provide sweetness to the food without increasing the blood sugar as much as sucrose.

Administration

When using mannitol for medical purposes, it is given intravenously. Mannitol can be found in varying concentrations from 5% mannitol (5 gm mannitol dissolved in 100 mL of fluid) up to 25% mannitol (25 gm of mannitol dissolved in 100 mL of fluid). A commonly encountered solution is 20% mannitol (20 grams of mannitol dissolved in 100 mL of fluid).[2]

  • For increased intracranial pressure dosages typically range 0.25 g/kg to 2 g/kg administered intravenously over 30 to 60 minutes with effect within 5 to 10 minutes and lasting up to approximately 6 hours.
  • For increased intraocular pressure dosages typically range 0.25 g/kg to 2 g/kg administered intravenously over 30 to 60 minutes with effect within 5 to 10 minutes and lasting up to approximately 6 hours.
  • For prevention or treatment of oliguria, a test dose should be strongly considered of around 0.2 g/kg intravenous to ensure a response to urine output. The infusion of mannitol can be adjusted to provide a urine flow rate of at least 30 mL/hour to 50 mL/hour in adults.
  • For excretion of toxic materials, the clinician may consider a dose of 0.25 g/kg to 2 g/kg with the observation of effects. If the patient receives more than 200 gm of mannitol without benefit, then mannitol use should be discontinued.

Adverse Effects

There are multiple adverse effects which mannitol can cause including:[7]

  • Masking or worsening dehydration as it causes diuresis
  • Precipitate heart failure due to the rapid fluid shifts as water enters the intravascular compartment
  • Cause or worsen electrolyte abnormalities due to the shift of free water into the intravascular space. Electrolyte abnormalities may include but are not limited to, hyponatremia, hypokalemia, and hypocalcemia
  • Precipitate into crystals at low temperatures which can cause vascular and end-organ damage
  • Worsen cerebral edema. Although mannitol poorly crosses the vessel wall, it does cross to some degree. Mannitol more easily crosses injured vessels such as patients with intracranial hemorrhage. Frequent doses of mannitol can cause mannitol to leach across the blood-brain barrier and worsen cerebral edema as the mannitol which has leeched into the brain draws water into instead of out of the brain. Patients, especially children, with cerebral hyperemia may have worsening cerebral edema with mannitol administration.

Contraindications

There are multiple contraindications to giving mannitol, including[8]:

  • Established anuria due to renal disease
  • Pulmonary edema or severe pulmonary congestion
  • Active intracranial bleeding except for during a current craniotomy
  • Severe dehydration
  • Progressive heart failure
  • Know mannitol hypersensitivity
  • Renal damage caused by mannitol
  • Impaired renal function.  If the patient has impaired renal function, a small test dose should be given, and the patient observed for a response. If there is no response, a small test dose is repeatable, but the clinician should administer no more than two test doses.
  • Electrolyte abnormalities. As mannitol works, it first increases the intravascular free water content which can worsen electrolyte abnormalities including hyponatremia. In the second phase of action, mannitol gets excreted in the urine with excess free water, which can cause hypernatremia due to the induced diuresis. Electrolytes should be monitored carefully with mannitol use. 
  • Mannitol may worsen intracranial hypertension in patients, especially children, with hyperemia, which can be fatal.
  • Repeated frequent doses of mannitol can leach into the brain, and worsen cerebral edema in the long term. Thus, mannitol is frequently recommended a bolus spaced apart every 6 to 8 hours and limiting the number of boluses given.
  • Mannitol can worsen renal function and precipitate renal failure.
  • Mannitol should only be given intravenously and never given intramuscularly or subcutaneously.
  • Mannitol should not be administered with whole blood.

Monitoring

When giving mannitol, it is essential to monitor cardiac function as the fluid shifts can precipitate heart failure. Additional electrolytes, including sodium, potassium, and osmolality, all require monitoring. The clinician should stop mannitol if significant electrolyte abnormalities develop or the osmolality reaches 320 mOsm or higher. Finally, urine output also requires monitoring; failure for urine output to increase after administration of mannitol should prompt cessation of mannitol and evaluation for possible renal or genitourinary issues.[8]

Toxicity

Dialysis partially removes mannitol. Repeated doses of mannitol lead to the build-up of mannitol even with dialysis.

Enhancing Healthcare Team Outcomes

A multidisciplinary team approach is an optimal approach with mannitol administration. It is essential to monitor cardiac function as the fluid shifts can precipitate heart failure. Additional electrolytes, including sodium, potassium, and osmolality, require monitoring by the nurses and physicians. Abnormalities in these laboratory values necessitate prompt communication to all members of the team. Mannitol administration should stop if significant electrolyte abnormalities develop or the osmolality reaches 320 mOsm or higher. When mannitol is used to treat cerebral edema, serum osmolality should be checked every 4 to 6 hours. If serum osmolality is more than 320 mOsm, alternative agents like the hypertonic solution should be used.

The nursing staff should pay particular attention to urine output and monitor it carefully, reporting any concerns to the treating physician. The pharmacist can verify dosing and perform medication reconciliation and alert the team if any interactions are present. They can also collaborate with the treating physician regarding potential alternative therapies in the event of therapeutic failure or intolerance of mannitol. Only with open interprofessional communication between all members of the healthcare team can any therapy, including mannitol, have the best chance at optimal results. [Level V]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Mannitol - Questions

Take a quiz of the questions on this article.

Take Quiz
A patient in the ICU develops multi-organ failure and requires inotropic support. Due to massive fluid overload, the patient is treated with mannitol. Which of the following statements about mannitol is not correct?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following should be monitored most closely during the administration of mannitol to treat increased intracranial pressure?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What of the following statements about mannitol is true?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
How does mannitol decrease intracranial pressure?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
By what mechanism can mannitol induce a subdural hematoma?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following parameters should be monitored in a patient receiving repeated doses of mannitol?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following drugs is an osmotic diuretic?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which lyophilized product is included as a bulking agent?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 65-year old male recently underwent a difficult colon resection and is in the ICU with signs of heart failure. His urine output had dropped to less than 10 ml/hour, and he has developed significant edema and ascites. His ejection fraction is about 40%, but his renal function seems intact. Which of the following may be of the most benefit to him?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is a sweetener commonly utilized in chewable tablet formulations?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 17-year-old female falls from 15 feet to a concrete floor. At the scene she is moaning, eyes closed, and localizing to pain. Pupils are equally round and reactive to light at 4 mm at the scene. She is transported to the hospital and deteriorates during transport. At arrival at the emergency department, she does not open eyes to noxious stimuli, is intubated and extensor postures in the upper extremities to noxious stimuli. Her right pupil is 8 mm and non-reactive, and her left pupil is 3 mm and reactive. A computed tomography scan of her head shows significant right cerebral edema and uncal herniation. A decision is made to give her mannitol while getting her to the operating room. Which of the following is the correct dose of mannitol to give?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Mannitol is best classified as which of the following?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not an FDA approved indication for mannitol?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following patients is a candidate for mannitol?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Mannitol - References

References

Mannitol for acute traumatic brain injury., Wakai A,McCabe A,Roberts I,Schierhout G,, The Cochrane database of systematic reviews, 2013 Aug 5     [PubMed]
Effect of mannitol on globe and orbital volumes in humans., Weber AC,Blandford AD,Costin BR,Perry JD,, European journal of ophthalmology, 2017 Aug 2     [PubMed]
A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury., Alnemari AM,Krafcik BM,Mansour TR,Gaudin D,, World neurosurgery, 2017 Oct     [PubMed]
Hypertonic Saline for Increased Intracranial Pressure After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review., Pasarikovski CR,Alotaibi NM,Al-Mufti F,Macdonald RL,, World neurosurgery, 2017 Sep     [PubMed]
Mesghali E,Fitter S,Bahjri K,Moussavi K, Safety of Peripheral Line Administration of 3% Hypertonic Saline and Mannitol in the Emergency Department. The Journal of emergency medicine. 2019 Feb 8;     [PubMed]
Rossi S,Picetti E,Zoerle T,Carbonara M,Zanier ER,Stocchetti N, Fluid Management in Acute Brain Injury. Current neurology and neuroscience reports. 2018 Sep 11;     [PubMed]
Koenig MA, Cerebral Edema and Elevated Intracranial Pressure. Continuum (Minneapolis, Minn.). 2018 Dec;     [PubMed]
Mc Causland FR,Prior LM,Heher E,Waikar SS, Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation. American journal of nephrology. 2012     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Ophthalmology. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Ophthalmology, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Ophthalmology, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Ophthalmology. When it is time for the Surgery-Ophthalmology board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Ophthalmology.